Journal
IMMUNITY
Volume 34, Issue 4, Pages 527-540Publisher
CELL PRESS
DOI: 10.1016/j.immuni.2011.03.015
Keywords
-
Categories
Funding
- Marie-Curie Intereuropean Fellowship
- Flemish Organization for Scientific Research (FWO)
- European Research Council
- Ghent University
- NIH [R21]
- Austrian Science Fund (FWF) [R21] Funding Source: Austrian Science Fund (FWF)
Ask authors/readers for more resources
Although deposition of uric acid (UA) crystals is known as the cause of gout, it is unclear whether UA plays a role in other inflammatory diseases. We here have shown that UA is released in the airways of allergen-challenged asthmatic patients and mice, where it was necessary for mounting T helper 2 (Th2) cell immunity, airway eosinophilia, and bronchial hyperreactivity to inhaled harmless proteins and clinically relevant house dust mite allergen. Conversely, administration of UA crystals together with protein antigen was sufficient to promote Th2 cell immunity and features of asthma. The adjuvant effects of UA did not require the inflammasome (NIrp3, Pycard) or the interleukin-1 (Myd88, IL-1r) axis. UA crystals promoted Th2 cell immunity by activating dendritic cells through spleen tyrosine kinase and PI3-kinase delta signaling. These findings provide further molecular insight into Th2 cell development and identify UA as an essential initiator and amplifier of allergic inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available